GLP-1 Market
LLY $1157.49 ▲ +1.3% NVO $37.53 ▼ -0.0% PFE $27.50 ▲ +0.3% VKTX $28.38 ▼ -3.1% KLRA $10.83 ▼ -0.1% GPCR $27.47 ▼ -0.4% RHHBY $52.55 ▲ +0.1%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Vitamin D₃ alone

Company
University of Jordan
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Oct 7, 2026

Trial details
  • Completed NCT NCT00135304

    ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

    Not yet reported Amgen 170 participants Est. completion 2006-12
    Other conditions: Secondary Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT02271230

    Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure

    Not yet reported Brigham and Women's Hospital 25871 participants Est. completion 2019-12 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03871322

    The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures

    Not yet reported Medical University of Bialystok 90 participants Est. completion 2023-01-20 1 site
    Other conditions: Fracture Healing, Vitamin D3, Deficiency of Vitamin K2
    View official trial listing →
  • Completed NCT NCT07861464

    BPPV Recurrence After CRM With & Without Supplementation

    Not yet reported University of Jordan 404 participants Est. completion 2026-08-31 1 site
    Other conditions: Benign Paroxismal Positional Vertigo
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.